IMMUNOTHERAPEUTIC COMPOSITION FOR THE TREATMENT OF CANCER

Yoram Reiter (Inventor), Netta Haim (Inventor)

Research output: Patent

Abstract

The present invention provides compositions and methods for inducing allogenic tumor rejection and, more particularly, but not exclusively, compositions and methods employing fusion proteins comprising an MHC class I HLA amino acid sequence mismatched to the host.

Original languageAmerican English
Patent numberUS2020385441
IPCC07K 16/ 30 A I
Priority date20/08/20
StatePublished - 10 Dec 2020

Fingerprint

Dive into the research topics of 'IMMUNOTHERAPEUTIC COMPOSITION FOR THE TREATMENT OF CANCER'. Together they form a unique fingerprint.

Cite this